Physician profile
Denzel Cole
NPI 1528595717
$6,849.21
in general payments reported to CMS, 2019-2025
12 companies · $47.98 in 2025
The $47.98 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,846 · 2021: $1,505 · 2022: $100 · 2023: $1,945 · 2024: $404 · 2025: $47.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,123 · Food and Beverage: $1,023 · Education: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,122.68 |
| Food and Beverage | $1,023.23 |
| Education | $251.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,906.89 | 2019-2021 | |
| Philips North America LLC | $1,398.85 | 2023 | (9520) Igt Devices Undivided |
| Cook Incorporated | $1,144.01 | 2021 | |
| Sirtex Medical INC | $1,060.29 | 2019-2025 | Lava Les (Liquid Embolic System) |
| Cook Medical LLC | $341.29 | 2021-2022 | |
| Inari Medical, INC. | $315.13 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $310.81 | 2024 | Indigo System |
| Medtronic, INC. | $251.80 | 2023 | |
| Medtronic USA, INC. | $47.00 | 2019 | |
| Shockwave Medical, INC | $27.40 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bracco Diagnostics INC. | $23.35 | 2023 | |
| Abbott Laboratories | $22.39 | 2024 | Esprit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denzel Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.